Inceptix - Fiduciary Anti-Hype AI Ledger logo
Inceptix - Fiduciary Anti-Hype AI Ledger
Free AI Consult
Subscribe
  • Inceptix - Fiduciary Anti-Hype AI Ledger
  • Topics
  • Weekly SMB AI Essentials

Weekly SMB AI Essentials

Curated AI trends, use cases, and best practices tailored to SMB priorities

AI Integration and StrategyAI Basics for Business LeadersExecutive BriefsWeekly SMB AI EssentialsAI ToolsAI Ethics and GovernanceInfographicsCase StudiesLeadership in the AI EraAI Readiness ToolkitIndustry-Specific AI Applications
Weekly SMB AI EssentialsWeekly SMB AI Essentials
AI Sales Strategies Weekly: Boost B2B Revenue with AI
Nov 02, 2024

AI Sales Strategies Weekly: Boost B2B Revenue with AI

Explore AI-driven strategies, case studies, and expert insights designed to enhance B2B sales performance for SMBs and enterprise teams alike.

Cyrus Slayman
Cyrus Slayman
Weekly SMB AI EssentialsWeekly SMB AI Essentials
Boost Your SMB with AI: Weekly Insights Inside
Oct 26, 2024

Boost Your SMB with AI: Weekly Insights Inside

Curated AI trends, use cases, and best practices tailored to SMB priorities

Cyrus Slayman
Cyrus Slayman
Weekly SMB AI EssentialsWeekly SMB AI Essentials
SMB AI Essentials Weekly Newsletter
May 19, 2024

SMB AI Essentials Weekly Newsletter

Curated AI trends, use cases, and best practices tailored to SMB priorities

Cyrus Slayman
Cyrus Slayman
Weekly SMB AI EssentialsWeekly SMB AI Essentials
SMB AI Essentials Weekly Newsletter
May 12, 2024

SMB AI Essentials Weekly Newsletter

Curated AI trends, use cases, and best practices tailored to SMB priorities

Cyrus Slayman
Cyrus Slayman
A straight-talk newsletter delivering fiduciary-level oversight and hype-free tactics for revenue-ready AI.

Inceptix - Fiduciary Anti-Hype AI Ledger

A straight-talk newsletter delivering fiduciary-level oversight and hype-free tactics for revenue-ready AI.

Home

Posts

FREE Strategy Call

Free AI Consult

© 2025 Inceptix - AI for Executives. Brought to you by TribeNomadik.

Privacy policy

Terms of use

Powered by beehiiv